Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. - Wikidata - wikimedia - TriplyDB

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

http://www.wikidata.org/entity/Q34256239

about

Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis Role for Tetrahydrobiopterin in the Fetoplacental Endothelial Dysfunction in Maternal Supraphysiological Hypercholesterolemia Endothelial cells derived from nuclear reprogramming Effects of BM-573 on Endothelial Dependent Relaxation and Increased Blood Pressure at Early Stages of Atherosclerosis Endothelial dysfunction: a comprehensive appraisal.Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo Assessment of forearm vasodilator responses to acetylcholine and albuterol by strain gauge plethysmography: reproducibility and influence of strain gauge placement Calf and forearm blood flow in hypercholesterolemic patients Aging and vascular endothelial function in humans Altered nitric oxide bioavailability contributes to diesel exhaust inhalation-induced cardiovascular dysfunction in man LDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and mortality?Update on nitric oxide-dependent vasodilation in human subjects Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease.Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure.Endothelium-dependent and endothelium-independent skin vasoreactivity in the elderly.The alpha-amino group of L-arginine mediates its antioxidant effect.Reduced responsiveness of cutaneous microcirculation in essential hypertension--a pilot study.Noninvasive measure of microvascular nitric oxide function in humans using very low-frequency cutaneous laser Doppler flow spectra Nitric oxide and prostaglandin inhibition during acetylcholine-mediated cutaneous vasodilation in humans Atherosclerosis: inhibition of regression as therapeutic possibilities Vascular dysfunction in retinopathy-an emerging role for arginase Cardiac markers: present and future.Acute effects of vinegar intake on some biochemical risk factors of atherosclerosis in hypercholesterolemic rabbits.Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase Fiber-rich diet with brown rice improves endothelial function in type 2 diabetes mellitus: A randomized controlled trial.Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome.Testing for endothelial dysfunction.Modulation of vascular endothelial function by low-density lipoprotein cholesterol with aging: influence of habitual exercise.Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.Role of nitric oxide in progression and regression of atherosclerosis Metabolomic analyses for atherosclerosis, diabetes, and obesity.L-arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance Markers for progression of coronary disease.Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications Obesity and Alzheimer's disease: a link between body weight and cognitive function in old age.Hypercholesterolemia impairs exercise capacity in mice.Assessing endothelial vasodilator function with the Endo-PAT 2000.Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy.

P2860

Q21195404-33C67340-FA58-4A90-9FB4-4E188CD4E94D Q26772291-75FA28D7-A3A1-4D6B-88DD-D59BA28AAB15 Q27011837-B395C6CD-2203-4309-9727-BA8D3D404ECF Q27315993-0886DA66-D52E-40AA-9BB7-C2E43E046FDE Q28195411-55AEA0C3-718D-4054-A783-0F9297AB8B8E Q28219328-C71471F3-C648-43A3-BA04-BD4D5B5776E7 Q28343977-BD4EBBA8-E8AB-4856-88D4-F7C16AB93D60 Q28362285-C658E504-F022-4B99-8203-FCBB6922F2CA Q28377505-8F3BB5EF-11AB-4FDA-BFEB-CF7C0EE134BA Q28390251-B4B40C93-B246-448A-83DC-7AC51F75DC10 Q28395952-E6CE1DFC-79A5-433A-A9D4-52E9FB60A5D8 Q30422549-750CAE04-8090-48B2-88D3-9780D810D8E4 Q30486656-A8727034-A401-4CC9-A197-79F95D237A35 Q30829627-4EFA3BEF-05EB-44DA-B956-24DBA385EA7B Q31105347-FF55A444-8F71-47C2-BB4C-E8ECB011EB21 Q31132838-46DF0978-6264-4137-B3D1-8A8544060472 Q31898256-769F24F7-8C6A-4855-A9C8-4F163B2FD5CC Q33279789-D7738CC1-3E80-41BE-9D21-FF892F12A1F6 Q33282580-F3A3A889-925C-4640-BADF-0FAB14530BFD Q33359424-A47F831C-FA19-4C2E-A0FC-D3A989CC2ED6 Q33611394-B943F3FE-AEAB-4A75-8F13-8F872BD9C8C6 Q33625727-8D23F075-45C1-4EDD-A1B6-85576555AE27 Q33704714-4CA94074-FB6D-4E1F-BEC6-6632382E06F7 Q33721364-52F23081-5E4E-4DE5-A430-4C4A98372F92 Q33844099-A86192C7-A225-4B11-BD0A-CCABD99DE4CC Q33853108-17CC6733-7941-4BB1-A56A-E8CBD0DF39DC Q33985524-C499D89B-D41C-4DC2-A8B0-68514613A1CD Q34008359-833798A0-D464-49AC-A642-9F1D1A27ABD4 Q34064636-0754420F-116B-4F5E-A0B1-8C3C2DFA378C Q34170380-BD0CF778-3BE1-4434-B318-A86606E49A8C Q34183363-CAA4C6BE-216A-4AE9-8974-5122F9DC1786 Q34256164-9AEDCEA5-DD21-4894-A16E-63B270FAE83D Q34345457-438A8D32-8AAB-492B-99AD-637CB1651C98 Q34371499-E2320125-4D4E-4798-9300-0E5A31E1DB67 Q34459056-F9AF37BF-0F9E-42A5-A41A-ED8A81E46A4F Q34659206-E7B87D8D-354D-4626-AA3F-961FFB00AE72 Q35117350-3F80CEA0-9856-4472-B5B4-AFA89D7B15F0 Q35126339-C9E1E1FA-C0A7-4E3B-9A5A-D28DB0D1DC78 Q35173610-776EC249-E324-4011-A46B-112559FF3E6E Q35579449-8BB282FC-7B22-4AA0-BC7D-5E5BF442DB82

P2860

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

http://www.wikidata.org/entity/Q34256239

description

1990 nî lūn-bûn

@nan

1990 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

@ast

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

@en

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

@nl

type

label

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

@ast

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

@en

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

@nl

prefLabel

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

@ast

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

@en

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

@nl

P1433

Q34256239-3CE0424B-C803-4C32-8F53-D88B43B95AE5

P1476

Q34256239-50548A0C-F5A1-4B00-8D3B-E319DB30A6CE

P2093

Q34256239-0DCC0440-6505-47C7-BA40-0F351B995350

Q34256239-283225F4-C7B4-4ED7-A7CF-7D7675A0DDD9

Q34256239-2B99F924-905A-46E2-9B5E-962C164A55DB

Q34256239-5037B7A2-AECC-4F5B-9D5E-627E5D16B0FE

Q34256239-5BB92225-B73C-4DE7-84A7-1E5261EFE701

Q34256239-5DB19DE8-3970-4ABE-86F9-5DB169636443

Q34256239-EF954AD7-E74D-41EE-A79F-47FFCDF735C9

P2860

Q34256239-0FD7673A-783E-43C3-AA0B-BF5F11E893B6

Q34256239-1080DDF4-FFF8-43E8-B371-A2FD9C1A74FE

Q34256239-13690E14-8A60-48D0-B4A2-97DFC44658B5

Q34256239-149791F5-AC7C-4D7C-A8AF-9DDD2FC21553

Q34256239-194A1D69-61E7-4E1B-86E4-56A049CFF611

Q34256239-1F450B1D-7FAF-499D-B62B-3C0131E4869D

Q34256239-3251F080-67B2-4D6E-9A75-F48BBEE1E773

Q34256239-372514C8-C241-4BA8-AEDF-05287CEBDCA0

Q34256239-4133FA47-8AB4-4515-81B7-02FC5BF2FDB5

Q34256239-52CCC6AE-F781-4E92-9781-468979D09604

P304

Q34256239-4DFD6578-2A34-42AA-A548-F7C5C2D84595

P31

Q34256239-9AF28C74-18E8-4373-8D2C-C5B5CFB8839B

P356

Q34256239-BEA9F344-3DBA-4FC8-BA40-43963B1286AE

P407

Q34256239-2ECF3C50-A808-4ED7-9AD3-ABFE55030C9F

P433

Q34256239-02E83165-906F-4BBF-99CF-1624CB7ABA21

P478

Q34256239-BACC4EA1-B2B8-4102-AA05-61DEE7E0B95A

P577

Q34256239-C9FA7787-226C-45AC-9B02-15DBF4EFBB59

P698

Q34256239-BB747923-0FB0-4A88-84B3-F603B1766994

P921

Q34256239-F00D467F-16BC-4E01-BF0A-037B548C969F

P932

Q34256239-CBFDC3CF-F664-421E-9D87-572AA35F6550

P356

P1433

Journal of Clinical Investigation

P1476

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

@en

P2093

J Loscalzo

http://www.w3.org/2001/XMLSchema#string

J P Cooke

http://www.w3.org/2001/XMLSchema#string

M A Creager

http://www.w3.org/2001/XMLSchema#string

M E Mendelsohn

http://www.w3.org/2001/XMLSchema#string

S J Gallagher

http://www.w3.org/2001/XMLSchema#string

S M Coleman

http://www.w3.org/2001/XMLSchema#string

V J Dzau

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclic guanosine monophosphate as a mediator of vasodilation

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta.

Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment.

Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis.

Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit.

Endothelium-dependent hyperpolarization of canine coronary smooth muscle.

Supersensitivity of atherosclerotic rabbit aorta to ergonovine. Mediation by a serotonergic mechanism.

Effects of hyperlipoproteinemias and their treatment on the peripheral circulation.

Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation.

P304

228-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI114688

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

1990-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2195060

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

296711

http://www.w3.org/2001/XMLSchema#string